Last reviewed · How we verify
NCT03032081
High Intensity Interval Training in Heart Failure
NA trial testing High intensity exercise in Heart Failure. Withdrawn.
1 July 2018
Quick facts
| Lead sponsor | Georgia State University |
|---|---|
| Phase | NA |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Start date | 2 March 2017 |
| Primary completion | 1 July 2018 |
| Estimated completion | 1 July 2018 |
| Sites | 1 location across United States |
Drugs / interventions tested
- High intensity exercise
- Moderate intensity exercise
Conditions studied
- Heart Failure — all drugs for Heart Failure →
- Physical Activity — all drugs for Physical Activity →
Sponsor
Georgia State University
Who can join
Adults 40 to 65, any sex, with Heart Failure or Physical Activity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators will assess the efficacy and safety of utilizing high-intensity interval training in stable heart failure patients on functional outcomes. Specifically, an assessment of baseline peak oxygen uptake and peak cardiac output will be assessed before and 8 weeks after intense interval training. Measurements of quality of life will be assessed before and after training as well as the number of arrhythmic events before and after training. The control group will be a group that will follow a moderate exercise training protocol over a similar period.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03032081
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of High intensity exercise
Trials testing the same drug.
- NCT07375420 — Will a Pre-therapy Exercise Intervention Improve the Outcomes of Patients With Advanced Oesophageal Cancer? · NA · recruiting
- NCT05777564 — Tolerability of High Intensity Exercise for Knee Osteoarthritis · NA · completed
- NCT05745922 — Acute Effects of Endurance Exercise on Breast Milk Composition in Women With Overweight/Obesity · NA · completed
- NCT05768165 — High-intensity Interval Exercise in Rheumatoid Arthritis · NA · active not recruiting
- NCT03335332 — High Intensity Exercise for Increasing Fitness in Patients With Hypertrophic Cardiomyopathy · NA · completed
Other recruiting trials for Heart Failure
Currently open trials in the same condition.
- NCT06118983 — Improving TRansitions ANd OutcomeS for Heart FailurE Patients in Home Health CaRe (I-TRANSFER-HF) · NA · recruiting
- NCT07496372 — Efficacy and Safety of Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Injection (HiCM-188) in Advanced Heart · Phase 3 · recruiting
- NCT07527156 — Prolonged Nasogastric Administration of Ketones in Decompensated Heart Failure · Phase 4 · recruiting
- NCT07263035 — Urine Sodium-Driven Diuretic Adjustment Strategy in Acute Decompensated Heart Failure · Phase 4 · recruiting
- NCT07531966 — Vascular Complications After Kidney Transplantation · recruiting
Other Georgia State University trials
Trials by the same sponsor.
- NCT07256275 — Peer Influences in Alcohol and Sexual Violence Among Marines Dyads · recruiting
- NCT06629428 — Effects of Ublituximab on Motor Functions in Multiple Sclerosis · EARLY_PHASE1 · recruiting
- NCT06787937 — Communicating About Nicotine Reduction in Cigarettes · NA · recruiting
- NCT06730646 — Testing Different Anti-smoking Messages Among Chinese Young Adult Smokers and Nonsmokers · NA · completed
- NCT06994624 — Clinical and Biochemical Effects of a Defined Plant-Based Diet on Heart Disease · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03032081 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Georgia State University
- Last refreshed: 23 August 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03032081.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing